Measuring respiratory syncytial virus infection severity in hospitalized children using the Pediatric Respiratory Syncytial Virus Electronic Severity and Outcome Rating System (PRESORS)

被引:3
|
作者
Vandendijck, Yannick [1 ]
Scott, Jane [2 ]
Heerwegh, Dirk [1 ]
Van der Elst, Wim [3 ]
Witek, James [4 ]
Sinha, Rekha [5 ]
Fennema, Hein [1 ]
机构
[1] Janssen Res & Dev LLC, Beerse, Belgium
[2] Janssen Global Serv LLC, High Wycombe, Bucks, England
[3] Janssen Pharmaceut, Beerse, Belgium
[4] Janssen Res & Dev LLC, Titusville, NJ USA
[5] Janssen Pharmaceut, Titusville, NJ USA
关键词
patient-reported outcome; pediatrics; psychometrics; respiratory syncytial virus; YOUNG-CHILDREN;
D O I
10.1111/irv.13028
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The Pediatric Respiratory Syncytial Virus Electronic Severity and Outcome Rating System (PRESORS) was developed to assess the severity of respiratory syncytial virus (RSV) infection in children. Because young children cannot report how they feel or function, ratings are based on observations by the child's caregiver (Observer-Reported Outcome questionnaire [ObsRO]) and clinician (Clinician-Reported Outcome questionnaire [ClinRO]). This prospective study aimed to evaluate the psychometric properties of the PRESORS. Methods The PRESORS version 6 ObsRO and ClinRO were evaluated in children with RSV infection requiring hospitalization in centers in the United States, Argentina, and Chile. Assessments were performed from days 1 to 7 by the child's caregiver and clinician. To assess inter-rater reliability, two clinicians independently performed the ClinRO near in time. Results A total of 124 children aged <= 36 months were enrolled (mean age, 8 months). Factor analysis demonstrated that RSV severity consists of two dimensions, respiratory signs and illness behavior, and that these dimensions were consistent over time. The inter-rater reliability for the ClinRO was 0.66 (95% confidence interval [CI], 0.55-0.75) but improved to 0.79 (95% CI, 0.71-0.86) after removing one outlying site, suggesting that quantifying RSV severity is not trivial, even using qualified raters, but that an adequate inter-rater reliability is achievable with the PRESORS through adequate training. ClinRO and ObsRO displayed acceptable internal consistency and acceptable convergent validity with the Respiratory Syncytial Virus Network Scale, global impression scores, and key hospital characteristics. Conclusions The PRESORS is relevant and appropriate for assessing the severity of RSV infection in infants requiring hospitalization.
引用
收藏
页码:1091 / 1100
页数:10
相关论文
共 50 条
  • [31] TNF-α genotypes and severity of illness during respiratory syncytial virus infection in hospitalized infants
    Gentile, DA
    Zeevi, A
    Howe-Adams, J
    Skoner, DP
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 12A - 12A
  • [32] Relationship between clinical severity of respiratory syncytial virus infection and subtype
    Kneyber, MCJ
    Brandenburg, AH
    Rothbarth, PH
    deGroot, R
    Ott, A
    vanSteenselMoll, HA
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 75 (02) : 137 - 140
  • [33] Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection
    Uusitupa, Erika
    Waris, Matti
    Heikkinen, Terho
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (02): : 298 - 304
  • [34] Clinical Disease Severity Scores and Viral Loads in Children With Respiratory Syncytial Virus Infection
    Mejias, Asuncion
    Brenes-Chacon, Helena
    Garcia-Maurino, Cristina
    Moore-Clingenpeel, Melissa
    Ramilo, Octavio
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : E1160 - E1162
  • [35] Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection
    Piters, Wouter A. A. de Steenhuijsen
    Heinonen, Santtu
    Hasrat, Raiza
    Bunsow, Eleonora
    Smith, Bennett
    Suarez-Arrabal, Maria -Carmen
    Chaussabel, Damien
    Cohen, Daniel M.
    Sanderl, Elisabeth A. M.
    Ramilo, Octavio
    Bogaert, Debby
    Mejias, Asuncion
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (09) : 1104 - 1115
  • [36] RESPIRATORY SYNCYTIAL VIRUS IN EARLY INFANCY - CIRCULATING ANTIBODY AND SEVERITY OF INFECTION
    BRUHN, FW
    YEAGER, AS
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1977, 131 (02): : 145 - 148
  • [37] Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update
    Vazquez, Yaneisi
    Gonzalez, Liliana
    Noguera, Loreani
    Gonzalez, Pablo A.
    Riedel, Claudia A.
    Bertrand, Pablo
    Bueno, Susan M.
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [38] Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants
    Buckingham, SC
    Bush, AJ
    Devincenzo, JP
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (02) : 113 - 117
  • [39] Preventing Pediatric Respiratory Syncytial Virus Infection
    Domachowske, Joseph
    Halczyn, Jodi
    Bonville, Cynthia A.
    [J]. PEDIATRIC ANNALS, 2018, 47 (09): : E371 - E376
  • [40] Relationship between respiratory syncytial virus load and illness severity in children
    DeVincenzo, JP
    Buckingham, SC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (09): : 1376 - 1377